S1P regulation of macrophage functions in the context of cancer

Anti-Cancer Agents in Medicinal Chemistry

Volumn 11, Issue 9, 2011, Pages 818-829

  Weigert, Andreas ^a   Weichand, Benjamin ^a   Brüne, Bernhard ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Apoptosis; Inflammation; Macrophages; Sphingolipids; Sphingosine kinase

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DIMETHYLSPINGOSINE; FINGOLIMOD; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 1; G PROTEIN COUPLED RECEPTOR 2; G PROTEIN COUPLED RECEPTOR 3; G PROTEIN COUPLED RECEPTOR 4; G PROTEIN COUPLED RECEPTOR 5; GRANULOCYTE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN BCL 2; PROTEIN BCL XL; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE DERIVATIVE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; ATHEROSCLEROSIS; CANCER SURVIVAL; CELL PROLIFERATION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; FOLLICULAR LYMPHOMA; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; INFLAMMATION; LARGE CELL LYMPHOMA; MACROPHAGE; MONOCYTE; NONHODGKIN LYMPHOMA; NONHUMAN; PHAGOCYTE; PROGNOSIS; SECOND MESSENGER; SIGNAL TRANSDUCTION; TUMOR IMMUNITY;

EID: 80054073822     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152011797655096     Document Type: Article

References (160)

1. Zhang, H.; Desai, N. N.; Olivera, A.; Seki, T.; Brooker, G.; Spiegel, S. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol., 1991, 114(1), 155-167.
2. Maceyka, M.; Payne, S. G.; Milstien, S.; Spiegel, S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta, 2002, 1585(2-3), 193-201.
3. Fyrst, H.; Saba, J. D. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat. Chem. Biol., 2010, 6(7), 489-497.
4. Hla, T. Physiological and pathological actions of sphingosine 1- phosphate. Semin. Cell Dev. Biol., 2004, 15(5), 513-520.
5. Spiegel, S.; Milstien, S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol. Cell. Biol., 2003, 4(5), 397-407.
6. Maceyka, M.; Sankala, H.; Hait, N. C.; Le Stunff, H.; Liu, H.; Toman, R.; Collier, C.; Zhang, M.; Satin, L. S.; Merrill, A. H., Jr.; Milstien, S.; Spiegel, S. SphK1 and SphK2, sphingosine kinase isoenzymes with opposing functions in sphingolipid metabolism. J. Biol. Chem., 2005, 280(44), 37118-37129.
7. Alvarez, S. E.; Harikumar, K. B.; Hait, N. C.; Allegood, J.; Strub, G. M.; Kim, E. Y.; Maceyka, M.; Jiang, H.; Luo, C.; Kordula, T.; Milstien, S.; Spiegel, S. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature, 2010, 465(7301), 1084-1088.
8. Hait, N. C.; Allegood, J.; Maceyka, M.; Strub, G. M.; Harikumar, K. B.; Singh, S. K.; Luo, C.; Marmorstein, R.; Kordula, T.; Milstien, S.; Spiegel, S. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science, 2009, 325(5945), 1254-1257.
9. Hla, T.; Lee, M. J.; Ancellin, N.; Paik, J. H.; Kluk, M. J. Lysophos-pholipids- receptor revelations. Science, 2001, 294(5548), 1875-1878.
10. Nieuwenhuis, B.; Luth, A.; Chun, J.; Huwiler, A.; Pfeilschifter, J.; Schafer-Korting, M.; Kleuser, B. Involvement of the ABCtransporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone. J. Mol. Med., 2009, 87(6), 645-657.
11. Mitra, P.; Oskeritzian, C. A.; Payne, S. G.; Beaven, M. A.; Milstien, S.; Spiegel, S. Role of ABCC1 in export of sphingosine-1- phosphate from mast cells. Proc. Natl. Acad. Sci. USA, 2006, 103(44), 16394-16399.
12. Kobayashi, N.; Nishi, T.; Hirata, T.; Kihara, A.; Sano, T.; Igarashi, Y.; Yamaguchi, A. Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. J. Lipid Res., 2006, 47(3), 614-621.
13. Kawahara, A.; Nishi, T.; Hisano, Y.; Fukui, H.; Yamaguchi, A.; Mochizuki, N. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science, 2009, 323(5913), 524-527.
14. Anelli, V.; Gault, C. R.; Snider, A. J.; Obeid, L. M. Role of sphingosine kinase-1 in paracrine/transcellular angiogenesis and lymphangiogenesis in vitro. Faseb J., 2010, 24(8), 2727-2738.
15. Takabe, K.; Kim, R. H.; Allegood, J. C.; Mitra, P.; Ramachandran, S.; Nagahashi, M.; Harikumar, K. B.; Hait, N. C.; Milstien, S.; Spiegel, S. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J. Biol. Chem., 2010, 285(14), 10477-10486.
16. Tani, M.; Ito, M.; Igarashi, Y. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell. Signal., 2007, 19(2), 229-237.
17. Venkataraman, K.; Thangada, S.; Michaud, J.; Oo, M. L.; Ai, Y.; Lee, Y. M.; Wu, M.; Parikh, N. S.; Khan, F.; Proia, R. L.; Hla, T. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem. J., 2006, 397(3), 461-471.
18. Hammad, S. M.; Taha, T. A.; Nareika, A.; Johnson, K. R.; Lopes- Virella, M. F.; Obeid, L. M. Oxidized LDL immune complexes induce release of sphingosine kinase in human U937 monocytic cells. Prostaglandins Other Lipid Mediat., 2006, 79(1-2), 126-140.
19. Weigert, A.; Cremer, S.; Schmidt, M. V.; von Knethen, A.; Angioni, C.; Geisslinger, G.; Brune, B. Cleavage of sphingosine kinase 2 by caspase-1 provokes its release from apoptotic cells. Blood, 2010, 115(17), 3531-3540.
20. Elliott, M. R.; Chekeni, F. B.; Trampont, P. C.; Lazarowski, E. R.; Kadl, A.; Walk, S. F.; Park, D.; Woodson, R. I.; Ostankovich, M.; Sharma, P.; Lysiak, J. J.; Harden, T. K.; Leitinger, N.; Ravichandran, K. S. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature, 2009, 461(7261), 282-286.
21. Weigert, A.; Tzieply, N.; von Knethen, A.; Johann, A. M.; Schmidt, H.; Geisslinger, G.; Brune, B. Tumor cell apoptosis polarizes macrophages role of sphingosine-1-phosphate. Mol. Biol. Cell, 2007, 18(10), 3810-3819.
22. Pappu, R.; Schwab, S. R.; Cornelissen, I.; Pereira, J. P.; Regard, J. B.; Xu, Y.; Camerer, E.; Zheng, Y. W.; Huang, Y.; Cyster, J. G.; Coughlin, S. R. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science, 2007, 316(5822), 295-298.
23. Le Stunff, H.; Milstien, S.; Spiegel, S. Generation and metabolism of bioactive sphingosine-1-phosphate. J. Cell. Biochem., 2004, 92(5), 882-899.
24. Murata, N.; Sato, K.; Kon, J.; Tomura, H.; Yanagita, M.; Kuwabara, A.; Ui, M.; Okajima, F. Interaction of sphingosine 1- phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem. J., 2000, 352 Pt 3, 809-815.
25. Mizugishi, K.; Yamashita, T.; Olivera, A.; Miller, G. F.; Spiegel, S.; Proia, R. L. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol., 2005, 25(24), 11113-11121.
26. Liu, H.; Sugiura, M.; Nava, V. E.; Edsall, L. C.; Kono, K.; Poulton, S.; Milstien, S.; Kohama, T.; Spiegel, S. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem., 2000, 275(26), 19513-19520.
27. Kono, M.; Mi, Y.; Liu, Y.; Sasaki, T.; Allende, M. L.; Wu, Y. P.; Yamashita, T.; Proia, R. L. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J. Biol. Chem., 2004, 279(28), 29367-29373.
28. Sanna, M. G.; Liao, J.; Jo, E.; Alfonso, C.; Ahn, M. Y.; Peterson, M. S.; Webb, B.; Lefebvre, S.; Chun, J.; Gray, N.; Rosen, H. Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate. J. Biol. Chem., 2004, 279(14), 13839-13848.
29. Graler, M. H.; Bernhardt, G.; Lipp, M. EDG6, a novel G-proteincoupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue. Genomics, 1998, 53(2), 164-169.
30. Walzer, T.; Chiossone, L.; Chaix, J.; Calver, A.; Carozzo, C.; Garrigue- Antar, L.; Jacques, Y.; Baratin, M.; Tomasello, E.; Vivier, E. Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat. Immunol., 2007, 8(12), 1337-1344.
31. Weigert, A.; Jennewein, C.; Brune, B. The liaison between apoptotic cells and macrophages--the end programs the beginning. Biol. Chem., 2009, 390(5-6), 379-390.
32. Idzko, M.; Hammad, H.; van Nimwegen, M.; Kool, M.; Muller, T.; Soullie, T.; Willart, M. A.; Hijdra, D.; Hoogsteden, H. C.; Lambrecht, B. N. Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function. J. Clin. Invest., 2006, 116(11), 2935-2944.
33. Terai, K.; Soga, T.; Takahashi, M.; Kamohara, M.; Ohno, K.; Yatsugi, S.; Okada, M.; Yamaguchi, T. Edg-8 receptors are preferentially expressed in oligodendrocyte lineage cells of the rat CNS. Neuroscience, 2003, 116(4), 1053-1062.
34. Sanchez, T.; Hla, T. Structural and functional characteristics of S1P receptors. J. Cell. Biochem., 2004, 92(5), 913-922.
35. Rosen, H.; Sanna, G.; Alfonso, C. Egress: a receptor-regulated step in lymphocyte trafficking. Immunol. Rev., 2003, 195, 160-177.
36. Pinschewer, D. D.; Ochsenbein, A. F.; Odermatt, B.; Brinkmann, V.; Hengartner, H.; Zinkernagel, R. M. FTY720 immunosuppression impairs effector T cell peripheral homing without affecting induction, expansion, and memory. J. Immunol., 2000, 164(11), 5761-5770.
37. Mandala, S.; Hajdu, R.; Bergstrom, J.; Quackenbush, E.; Xie, J.; Milligan, J.; Thornton, R.; Shei, G. J.; Card, D.; Keohane, C.; Rosenbach, M.; Hale, J.; Lynch, C. L.; Rupprecht, K.; Parsons, W.; Rosen, H. Alteration of lymphocyte trafficking by sphingosine-1- phosphate receptor agonists. Science, 2002, 296(5566), 346-349.
38. Radeke, H. H.; von Wenckstern, H.; Stoidtner, K.; Sauer, B.; Hammer, S.; Kleuser, B. Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52. J. Immunol., 2005, 174(5), 2778-2786.
39. Lee, H.; Liao, J. J.; Graeler, M.; Huang, M. C.; Goetzl, E. J. Lysophospholipid regulation of mononuclear phagocytes. Biochim. Biophys. Acta, 2002, 1582(1-3), 175-177.
40. Matloubian, M.; Lo, C. G.; Cinamon, G.; Lesneski, M. J.; Xu, Y.; Brinkmann, V.; Allende, M. L.; Proia, R. L.; Cyster, J. G. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature, 2004, 427(6972), 355-360.
41. Bankovich, A. J.; Shiow, L. R.; Cyster, J. G. CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4. J. Biol. Chem., 2010, 285(29), 22328-22337.
42. Liu, G.; Burns, S.; Huang, G.; Boyd, K.; Proia, R. L.; Flavell, R. A.; Chi, H. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol., 2009, 10(7), 769-777.
43. Wang, W.; Graeler, M. H.; Goetzl, E. J. Type 4 sphingosine 1- phosphate G protein-coupled receptor (S1P4) transduces S1P effects on T cell proliferation and cytokine secretion without signaling migration. FASEB J., 2005, 19(12), 1731-1733.
44. Cinamon, G.; Zachariah, M. A.; Lam, O. M.; Foss, F. W., Jr.; Cyster, J. G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol., 2008, 9(1), 54-62.
45. Cattoretti, G.; Mandelbaum, J.; Lee, N.; Chaves, A. H.; Mahler, A. M.; Chadburn, A.; Dalla-Favera, R.; Pasqualucci, L.; MacLennan, A. J. Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation. Cancer Res., 2009, 69(22), 8686-8692.
46. Czeloth, N.; Bernhardt, G.; Hofmann, F.; Genth, H.; Forster, R. Sphingosine-1-phosphate mediates migration of mature dendritic cells. J. Immunol., 2005, 175(5), 2960-2967.
47. Graler, M. H.; Grosse, R.; Kusch, A.; Kremmer, E.; Gudermann, T.; Lipp, M. The sphingosine 1-phosphate receptor S1P4 regulates cell shape and motility via coupling to Gi and G12/13. J. Cell. Biochem., 2003, 89(3), 507-519.
48. Rathinasamy, A.; Czeloth, N.; Pabst, O.; Forster, R.; Bernhardt, G. The origin and maturity of dendritic cells determine the pattern of sphingosine 1-phosphate receptors expressed and required for efficient migration. J. Immunol., 2010, 185(7), 4072-4081.
49. Rivera, J.; Proia, R. L.; Olivera, A. The alliance of sphingosine-1- phosphate and its receptors in immunity. Nat. Rev. Immunol., 2008, 8(10), 753-763.
50. Duong, C. Q.; Bared, S. M.; Abu-Khader, A.; Buechler, C.; Schmitz, A.; Schmitz, G. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages. Biochim. Biophys. Acta, 2004, 1682(1-3), 112-119.
51. Fueller, M.; Wang, D. A.; Tigyi, G.; Siess, W. Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1- phosphate. Cell. Signal., 2003, 15(4), 367-375.
52. Rausch, M.; Hiestand, P.; Foster, C. A.; Baumann, D. R.; Cannet, C.; Rudin, M. Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxideenhanced magnetic resonance imaging. J. Magn. Reson. Imaging, 2004, 20(1), 16-24.
53. Muller, H.; Hofer, S.; Kaneider, N.; Neuwirt, H.; Mosheimer, B.; Mayer, G.; Konwalinka, G.; Heufler, C.; Tiefenthaler, M. The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. Eur. J. Immunol., 2005, 35(2), 533-545.
54. Gude, D. R.; Alvarez, S. E.; Paugh, S. W.; Mitra, P.; Yu, J.; Griffiths, R.; Barbour, S. E.; Milstien, S.; Spiegel, S. Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1- phosphate as a come-and-get-me signal. Faseb J., 2008, 22(8), 2629-2638.
55. Keul, P.; Tolle, M.; Lucke, S.; von Wnuck Lipinski, K.; Heusch, G.; Schuchardt, M.; van der Giet, M.; Levkau, B. The sphingosine- 1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol., 2007, 27(3), 607-613.
56. Theilmeier, G.; Schmidt, C.; Herrmann, J.; Keul, P.; Schafers, M.; Herrgott, I.; Mersmann, J.; Larmann, J.; Hermann, S.; Stypmann, J.; Schober, O.; Hildebrand, R.; Schulz, R.; Heusch, G.; Haude, M.; von Wnuck Lipinski, K.; Herzog, C.; Schmitz, M.; Erbel, R.; Chun, J.; Levkau, B. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation, 2006, 114(13), 1403-1409.
57. Du, W.; Takuwa, N.; Yoshioka, K.; Okamoto, Y.; Gonda, K.; Sugihara, K.; Fukamizu, A.; Asano, M.; Takuwa, Y. S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice. Cancer Res., 2010, 70(2), 772-781.
58. Gordon, S. The macrophage. Bioessays, 1995, 17(11), 977-86.
59. Stout, R. D.; Jiang, C.; Matta, B.; Tietzel, I.; Watkins, S. K.; Suttles, J. Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences. J. Immunol., 2005, 175(1), 342-349.
60. Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol., 2003, 3(1), 23-35.
61. Gordon, S.; Taylor, P. R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol., 2005, 5(12), 953-964.
62. Mackaness, G. B. The Immunological Basis of Acquired Cellular Resistance. J. Exp. Med., 1964, 120, 105-120.
63. Mackaness, G. B. Cellular immunity and the parasite. Adv. Exp. Med. Biol., 1977, 93, 65-73.
64. Mantovani, A.; Sozzani, S.; Locati, M.; Allavena, P.; Sica, A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol., 2002, 23(11), 549-555.
65. Mantovani, A.; Sica, A.; Locati, M. Macrophage polarization comes of age. Immunity, 2005, 23(4), 344-346.
66. Mosser, D. M.; Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol., 2008, 8(12), 958-969.
67. Martinez, F. O.; Gordon, S.; Locati, M.; Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol., 2006, 177(10), 7303-7311.
68. Edwards, J. P.; Zhang, X.; Frauwirth, K. A.; Mosser, D. M. Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol., 2006, 80(6), 1298-1307.
69. Weigert, A.; Weis, N.; Brune, B. Regulation of macrophage function by sphingosine-1-phosphate. Immunobiology, 2009, 214(9-10), 748-760.
70. Pchejetski, D.; Nunes, J.; Coughlan, K.; Lall, H.; Pitson, S. M.; Waxman, J.; Sumbayev, V. V. The involvement of sphingosine kinase 1 in LPS-induced Toll-like receptor 4-mediated accumulation of HIF-1alpha protein, activation of ASK1 and production of the pro-inflammatory cytokine IL-6. Immunol. Cell Biol., 2011, 89(2), 268-274.
71. Melendez, A. J.; Ibrahim, F. B. Antisense knockdown of sphingosine kinase 1 in human macrophages inhibits C5a receptordependent signal transduction, Ca2+ signals, enzyme release, cytokine production, and chemotaxis. J. Immunol., 2004, 173(3), 1596-1603.
72. Zhi, L.; Leung, B. P.; Melendez, A. J. Sphingosine kinase 1 regulates pro-inflammatory responses triggered by TNFalpha in primary human monocytes. J. Cell. Physiol., 2006, 208(1), 109-115.
73. Sethu, S.; Mendez-Corao, G.; Melendez, A. J. Phospholipase D1 plays a key role in TNF-alpha signaling. J. Immunol., 2008, 180(9), 6027-6034.
74. Nayak, D.; Huo, Y.; Kwang, W. X.; Pushparaj, P. N.; Kumar, S. D.; Ling, E. A.; Dheen, S. T. Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia. Neuroscience, 2010, 166(1), 132-144.
75. Yadav, M.; Clark, L.; Schorey, J. S. Macrophage's proinflammatory response to a mycobacterial infection is dependent on sphingosine kinase-mediated activation of phosphatidylinositol phospholipase C, protein kinase C, ERK1/2, and phosphatidylinositol 3- kinase. J. Immunol., 2006, 176(9), 5494-5503.
76. Prakash, H.; Luth, A.; Grinkina, N.; Holzer, D.; Wadgaonkar, R.; Gonzalez, A. P.; Anes, E.; Kleuser, B. Sphingosine kinase-1 (SphK-1) regulates Mycobacterium smegmatis infection in macrophages. PLoS One, 2010, 5(5), e10657.
77. Xia, P.; Wang, L.; Moretti, P. A.; Albanese, N.; Chai, F.; Pitson, S. M.; D'Andrea, R. J.; Gamble, J. R.; Vadas, M. A. Sphingosine kinase interacts with TRAF2 and dissects tumor necrosis factoralpha signaling. J. Biol. Chem., 2002, 277(10), 7996-8003.
78. Vlasenko, L. P.; Melendez, A. J. A critical role for sphingosine kinase in anaphylatoxin-induced neutropenia, peritonitis, and cytokine production in vivo. J. Immunol., 2005, 174(10), 6456-6461.
79. Puneet, P.; Yap, C. T.; Wong, L.; Lam, Y.; Koh, D. R.; Moochhala, S.; Pfeilschifter, J.; Huwiler, A.; Melendez, A. J. SphK1 regulates proinflammatory responses associated with endotoxin and polymicrobial sepsis. Science, 2010, 328(5983), 1290-1294.
80. Hammad, S. M.; Crellin, H. G.; Wu, B. X.; Melton, J.; Anelli, V.; Obeid, L. M. Dual and distinct roles for sphingosine kinase 1 and sphingosine 1 phosphate in the response to inflammatory stimuli in RAW macrophages. Prostaglandins Other Lipid Mediat., 2008, 85(3-4), 107-114.
81. Baker, D. A.; Barth, J.; Chang, R.; Obeid, L. M.; Gilkeson, G. S. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alphainduced arthritis. J. Immunol., 2010, 185(4), 2570-2579.
82. Lai, W. Q.; Irwan, A. W.; Goh, H. H.; Melendez, A. J.; McInnes, I. B.; Leung, B. P. Distinct roles of sphingosine kinase 1 and 2 in murine collagen-induced arthritis. J. Immunol., 2009, 183(3), 2097-2103.
83. Michaud, J.; Kohno, M.; Proia, R. L.; Hla, T. Normal acute and chronic inflammatory responses in sphingosine kinase 1 knockout mice. FEBS Lett., 2006, 580(19), 4607-4612.
84. Zemann, B.; Urtz, N.; Reuschel, R.; Mechtcheriakova, D.; Bornancin, F.; Badegruber, R.; Baumruker, T.; Billich, A. Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice. Immunol. Lett., 2007, 109(1), 56-63.
85. McQuiston, T.; Luberto, C.; Del Poeta, M. Role of host sphingosine kinase 1 in the lung response against Cryptococcosis. Infect. Immun., 2010, 78(5), 2342-2352.
86. Hornuss, C.; Hammermann, R.; Fuhrmann, M.; Juergens, U. R.; Racke, K. Human and rat alveolar macrophages express multiple EDG receptors. Eur. J. Pharmacol., 2001, 429(1-3), 303-308.
87. Gutierrez, M. G.; Gonzalez, A. P.; Anes, E.; Griffiths, G. Role of lipids in killing mycobacteria by macrophages: evidence for NFkappaB- dependent and -independent killing induced by different lipids. Cell. Microbiol., 2009, 11(3), 406-420.
88. Anes, E.; Kuhnel, M. P.; Bos, E.; Moniz-Pereira, J.; Habermann, A.; Griffiths, G. Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria. Nat. Cell. Biol., 2003, 5(9), 793-802.
89. Hughes, J. E.; Srinivasan, S.; Lynch, K. R.; Proia, R. L.; Ferdek, P.; Hedrick, C. C. Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circ. Res., 2008, 102(8), 950-958.
90. Weis, N.; Weigert, A.; von Knethen, A.; Brune, B. Heme oxygenase- 1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol. Biol. Cell, 2009, 20(5), 1280-1288.
91. Duenas, A. I.; Aceves, M.; Fernandez-Pisonero, I.; Gomez, C.; Orduna, A.; Crespo, M. S.; Garcia-Rodriguez, C. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate. Cardiovasc. Res., 2008, 79(3), 537-544.
92. Wang, F.; Okamoto, Y.; Inoki, I.; Yoshioka, K.; Du, W.; Qi, X.; Takuwa, N.; Gonda, K.; Yamamoto, Y.; Ohkawa, R.; Nishiuchi, T.; Sugimoto, N.; Yatomi, Y.; Mitsumori, K.; Asano, M.; Kinoshita, M.; Takuwa, Y. Sphingosine-1-phosphate receptor-2 deficiency leads to inhibition of macrophage proinflammatory activities and atherosclerosis in apoE-deficient mice. J. Clin. Invest., 2010, 120(11), 3979-3995.
93. Skoura, A.; Michaud, J.; Im, D. S.; Thangada, S.; Xiong, Y.; Smith, J. D.; Hla, T. Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2011, 31(1), 81-85.
94. Nofer, J. R.; Bot, M.; Brodde, M.; Taylor, P. J.; Salm, P.; Brinkmann, V.; van Berkel, T.; Assmann, G.; Biessen, E. A. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice. Circulation, 2007, 115(4), 501-508.
95. Barra, V.; Kuhn, A. M.; von Knethen, A.; Weigert, A.; Brune, B. Apoptotic cell-derived factors induce arginase II expression in murine macrophages by activating ERK5/CREB. Cell. Mol. Life Sci., 2011, 68(10), 1815-1827.
96. Jiang, L. I.; Collins, J.; Davis, R.; Lin, K. M.; DeCamp, D.; Roach, T.; Hsueh, R.; Rebres, R. A.; Ross, E. M.; Taussig, R.; Fraser, I.; Sternweis, P. C. Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway. J. Biol. Chem., 2007, 282(14), 10576-10584.
97. Johann, A. M.; Weigert, A.; Eberhardt, W.; Kuhn, A. M.; Barra, V.; von Knethen, A.; Pfeilschifter, J. M.; Brune, B. Apoptotic cell-derived sphingosine-1-phosphate promotes HuR-dependent cyclooxygenase-2 mRNA stabilization and protein expression. J. Immunol., 2008, 180(2), 1239-1248.
98. Bystrom, J.; Evans, I.; Newson, J.; Stables, M.; Toor, I.; van Rooijen, N.; Crawford, M.; Colville-Nash, P.; Farrow, S.; Gilroy, D. W. Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood, 2008, 112(10), 4117-4127.
99. Spiegel, S. Sphingosine 1-phosphate: a ligand for the EDG-1 family of G-protein-coupled receptors. Ann. N. Y. Acad. Sci., 2000, 905, 54-60.
100. Kroemer, G.; Galluzzi, L.; Vandenabeele, P.; Abrams, J.; Alnemri, E. S.; Baehrecke, E. H.; Blagosklonny, M. V.; El-Deiry, W. S.; Golstein, P.; Green, D. R.; Hengartner, M.; Knight, R. A.; Kumar, S.; Lipton, S. A.; Malorni, W.; Nunez, G.; Peter, M. E.; Tschopp, J.; Yuan, J.; Piacentini, M.; Zhivotovsky, B.; Melino, G. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ., 2009, 16(1), 3-11.
101. Serhan, C. N.; Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol., 2005, 6(12), 1191-1197.
102. Weigert, A.; Johann, A. M.; von Knethen, A.; Schmidt, H.; Geisslinger, G.; Brune, B. Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1- phosphate. Blood, 2006, 108(5), 1635-1642.
103. Gomez-Munoz, A.; Kong, J.; Salh, B.; Steinbrecher, U. P. Sphingosine- 1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett., 2003, 539(1-3), 56-60.
104. Cuvillier, O.; Pirianov, G.; Kleuser, B.; Vanek, P. G.; Coso, O. A.; Gutkind, S.; Spiegel, S. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature, 1996, 381(6585), 800-803.
105. Wu, W.; Mosteller, R. D.; Broek, D. Sphingosine kinase protects lipopolysaccharide-activated macrophages from apoptosis. Mol. Cell. Biol., 2004, 24(17), 7359-7369.
106. Chen, J. H.; Riazy, M.; Wang, S. W.; Dai, J. M.; Duronio, V.; Steinbrecher, U. P. Sphingosine kinase regulates oxidized low density lipoprotein-mediated calcium oscillations and macrophage survival. J. Lipid Res., 2010, 51(5), 991-998.
107. Ding, X. Z.; Feng, X. R.; Borschel, R. H.; Nikolich, M. P.; Feng, J.; Li, Y. S.; Hoover, D. L. HSP-70 mitigates LPS/SKI-induced cell damage by increasing sphingosine kinase 1 (SK1). Prostaglandins Other Lipid Mediat., 2010, 92(1-4), 1-7.
108. Schwab, S. R.; Cyster, J. G. Finding a way out: lymphocyte egress from lymphoid organs. Nat. Immunol., 2007, 8(12), 1295-1301.
109. Keul, P.; Lucke, S.; von Wnuck Lipinski, K.; Bode, C.; Graler, M.; Heusch, G.; Levkau, B. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ. Res., 2011, 108(3), 314-323.
110. Kuehnel, M. P.; Reiss, M.; Anand, P. K.; Treede, I.; Holzer, D.; Hoffmann, E.; Klapperstueck, M.; Steinberg, T. H.; Markwardt, F.; Griffiths, G. Sphingosine-1-phosphate receptors stimulate macrophage plasma-membrane actin assembly via ADP release, ATP synthesis and P2X7R activation. J. Cell Sci., 2009, 122(Pt 4), 505-512.
111. Michaud, J.; Im, D. S.; Hla, T. Inhibitory role of sphingosine 1- phosphate receptor 2 in macrophage recruitment during inflammation. J. Immunol., 2010, 184(3), 1475-1483.
112. Geissmann, F.; Manz, M. G.; Jung, S.; Sieweke, M. H.; Merad, M.; Ley, K. Development of monocytes, macrophages, and dendritic cells. Science, 2010, 327(5966), 656-661.
113. Zhang, Z.; Zhang, Z. Y.; Fauser, U.; Schluesener, H. J. FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves. Exp. Neurol., 2008, 210(2), 681-690.
114. Fujino, M.; Funeshima, N.; Kitazawa, Y.; Kimura, H.; Amemiya, H.; Suzuki, S.; Li, X. K. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J. Pharmacol. Exp. Ther., 2003, 305(1), 70-77.
115. Martini, S.; Kramer, S.; Loof, T.; Wang-Rosenke, Y.; Daig, U.; Budde, K.; Neumayer, H. H.; Peters, H. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis. Am. J. Physiol. Renal. Physiol., 2007, 292(6), F1761-1770.
116. Singer, II; Tian, M.; Wickham, L. A.; Lin, J.; Matheravidathu, S. S.; Forrest, M. J.; Mandala, S.; Quackenbush, E. J. Sphingosine-1- phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes. J. Immunol., 2005, 175(11), 7151-7161.
117. Hla, T.; Venkataraman, K.; Michaud, J. The vascular S1P gradientcellular sources and biological significance. Biochim. Biophys. Acta, 2008, 1781(9), 477-482.
118. Xie, B.; Shen, J.; Dong, A.; Rashid, A.; Stoller, G.; Campochiaro, P. A. Blockade of sphingosine-1-phosphate reduces macrophage influx and retinal and choroidal neovascularization. J. Cell. Physiol., 2009, 218(1), 192-198.
119. Aoki, S.; Yatomi, Y.; Shimosawa, T.; Yamashita, H.; Kitayama, J.; Tsuno, N. H.; Takahashi, K.; Ozaki, Y. The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins alpha(5)beta(1) and alpha(v)beta(3). J. Thromb. Haemost., 2007, 5(6), 1292-1301.
120. Bolick, D. T.; Srinivasan, S.; Kim, K. W.; Hatley, M. E.; Clemens, J. J.; Whetzel, A.; Ferger, N.; Macdonald, T. L.; Davis, M. D.; Tsao, P. S.; Lynch, K. R.; Hedrick, C. C. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler. Thromb. Vasc. Biol., 2005, 25(5), 976-981.
121. De Palma, C.; Meacci, E.; Perrotta, C.; Bruni, P.; Clementi, E. Endothelial nitric oxide synthase activation by tumor necrosis factor alpha through neutral sphingomyelinase 2, sphingosine kinase 1, and sphingosine 1 phosphate receptors: a novel pathway relevant to the pathophysiology of endothelium. Arterioscler. Thromb. Vasc. Biol., 2006, 26(1), 99-105.
122. Schmidt, A.; Weber, O. F. In memoriam of Rudolf virchow: a historical retrospective including aspects of inflammation, infection and neoplasia. Contrib. Microbiol., 2006, 13, 1-15.
123. Dunn, G. P.; Old, L. J.; Schreiber, R. D. The three Es of cancer immunoediting. Annu. Rev. Immunol., 2004, 22, 329-360.
124. Teng, M. W.; Swann, J. B.; Koebel, C. M.; Schreiber, R. D.; Smyth, M. J. Immune-mediated dormancy: an equilibrium with cancer. J Leukoc Biol, 2008, 84(4), 988-93.
125. Berzofsky, J. A.; Terabe, M. NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis. J. Immunol., 2008, 180(6), 3627-3635.
126. Murdoch, C.; Giannoudis, A.; Lewis, C. E. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood, 2004, 104(8), 2224-2234.
127. Bingle, L.; Brown, N. J.; Lewis, C. E. The role of tumourassociated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol., 2002, 196(3), 254-265.
128. Qian, B. Z.; Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell, 2010, 141(1), 39-51.
129. Allavena, P.; Sica, A.; Garlanda, C.; Mantovani, A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev., 2008, 222, 155-161.
130. Lewis, C. E.; Pollard, J. W. Distinct role of macrophages in different tumor microenvironments. Cancer Res., 2006, 66(2), 605-612.
131. Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer, 2004, 4(1), 71-78.
132. Mantovani, A.; Allavena, P.; Sica, A. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur. J. Cancer, 2004, 40(11), 1660-1667.
133. Visentin, B.; Vekich, J. A.; Sibbald, B. J.; Cavalli, A. L.; Moreno, K. M.; Matteo, R. G.; Garland, W. A.; Lu, Y.; Yu, S.; Hall, H. S.; Kundra, V.; Mills, G. B.; Sabbadini, R. A. Validation of an antisphingosine- 1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell, 2006, 9(3), 225-238.
134. Herr, B.; Zhou, J.; Werno, C.; Menrad, H.; Namgaladze, D.; Weigert, A.; Dehne, N.; Brune, B. The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor-1alpha in macrophages via sphingosine-1-phosphate and transforming growth factor-beta. Blood, 2009, 114(10), 2140-2148.
135. Lee, H.; Deng, J.; Kujawski, M.; Yang, C.; Liu, Y.; Herrmann, A.; Kortylewski, M.; Horne, D.; Somlo, G.; Forman, S.; Jove, R.; Yu, H. STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nat. Med., 2010, 16(12), 1421-1428.
136. Du, W.; Takuwa, N.; Yoshioka, K.; Okamoto, Y.; Gonda, K.; Sugihara, K.; Fukamizu, A.; Asano, M.; Takuwa, Y. S1P(2), the G protein-coupled receptor for sphingosine-1-phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice. Cancer Res., 2010, 70(2), 772-781.
137. Swann, J. B.; Vesely, M. D.; Silva, A.; Sharkey, J.; Akira, S.; Schreiber, R. D.; Smyth, M. J. Demonstration of inflammationinduced cancer and cancer immunoediting during primary tumorigenesis. Proc. Natl. Acad. Sci. USA, 2008, 105(2), 652-656.
138. Weigert, A.; Schiffmann, S.; Sekar, D.; Ley, S.; Menrad, H.; Werno, C.; Grosch, S.; Geisslinger, G.; Brune, B. Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype. Int. J. Cancer, 2009, 125(9), 2114-2121.
139. Colby, T. V.; Hoppe, R. T.; Warnke, R. A. Hodgkin's disease: a clinicopathologic study of 659 cases. Cancer, 1982, 49(9), 1848-1858.
140. Ree, H. J.; Kadin, M. E. Macrophage-histiocytes in Hodgkin's disease. The relation of peanut-agglutinin-binding macrophagehistiocytes to clinicopathologic presentation and course of disease. Cancer, 1985, 56(2), 333-338.
141. Steidl, C.; Lee, T.; Shah, S. P.; Farinha, P.; Han, G.; Nayar, T.; Delaney, A.; Jones, S. J.; Iqbal, J.; Weisenburger, D. D.; Bast, M. A.; Rosenwald, A.; Muller-Hermelink, H. K.; Rimsza, L. M.; Campo, E.; Delabie, J.; Braziel, R. M.; Cook, J. R.; Tubbs, R. R.; Jaffe, E. S.; Lenz, G.; Connors, J. M.; Staudt, L. M.; Chan, W. C.; Gascoyne, R. D. Tumor-associated macrophages and survival in classic Hodgkin's lymphoma. N. Engl. J. Med., 2010, 362(10), 875-885.
142. Dave, S. S.; Wright, G.; Tan, B.; Rosenwald, A.; Gascoyne, R. D.; Chan, W. C.; Fisher, R. I.; Braziel, R. M.; Rimsza, L. M.; Grogan, T. M.; Miller, T. P.; LeBlanc, M.; Greiner, T. C.; Weisenburger, D. D.; Lynch, J. C.; Vose, J.; Armitage, J. O.; Smeland, E. B.; Kvaloy, S.; Holte, H.; Delabie, J.; Connors, J. M.; Lansdorp, P. M.; Ouyang, Q.; Lister, T. A.; Davies, A. J.; Norton, A. J.; Muller- Hermelink, H. K.; Ott, G.; Campo, E.; Montserrat, E.; Wilson, W. H.; Jaffe, E. S.; Simon, R.; Yang, L.; Powell, J.; Zhao, H.; Goldschmidt, N.; Chiorazzi, M.; Staudt, L. M. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med., 2004, 351(21), 2159-2169.
143. Farinha, P.; Masoudi, H.; Skinnider, B. F.; Shumansky, K.; Spinelli, J. J.; Gill, K.; Klasa, R.; Voss, N.; Connors, J. M.; Gascoyne, R. D. Analysis of multiple biomarkers shows that lymphoma- associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood, 2005, 106(6), 2169-2174.
144. Marmey, B.; Boix, C.; Barbaroux, J. B.; Dieu-Nosjean, M. C.; Diebold, J.; Audouin, J.; Fridman, W. H.; Mueller, C. G.; Molina, T. J. CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas. Hum. Pathol., 2006, 37(1), 68-77.
145. Lenz, G.; Wright, G.; Dave, S. S.; Xiao, W.; Powell, J.; Zhao, H.; Xu, W.; Tan, B.; Goldschmidt, N.; Iqbal, J.; Vose, J.; Bast, M.; Fu, K.; Weisenburger, D. D.; Greiner, T. C.; Armitage, J. O.; Kyle, A.; May, L.; Gascoyne, R. D.; Connors, J. M.; Troen, G.; Holte, H.; Kvaloy, S.; Dierickx, D.; Verhoef, G.; Delabie, J.; Smeland, E. B.; Jares, P.; Martinez, A.; Lopez-Guillermo, A.; Montserrat, E.; Campo, E.; Braziel, R. M.; Miller, T. P.; Rimsza, L. M.; Cook, J. R.; Pohlman, B.; Sweetenham, J.; Tubbs, R. R.; Fisher, R. I.; Hartmann, E.; Rosenwald, A.; Ott, G.; Muller-Hermelink, H. K.; Wrench, D.; Lister, T. A.; Jaffe, E. S.; Wilson, W. H.; Chan, W. C.; Staudt, L. M. Stromal gene signatures in large-B-cell lymphomas. N. Engl. J. Med., 2008, 359(22), 2313-2323.
146. Biswas, S. K.; Mantovani, A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol., 2010, 11(10), 889-896.
147. Burger, J. A.; Tsukada, N.; Burger, M.; Zvaifler, N. J.; Dell'Aquila, M.; Kipps, T. J. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood, 2000, 96(8), 2655-2663.
148. Burkle, A.; Niedermeier, M.; Schmitt-Graff, A.; Wierda, W. G.; Keating, M. J.; Burger, J. A. Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemia. Blood, 2007, 110(9), 3316-3325.
149. Zucchetto, A.; Benedetti, D.; Tripodo, C.; Bomben, R.; Dal Bo, M.; Marconi, D.; Bossi, F.; Lorenzon, D.; Degan, M.; Rossi, F. M.; Rossi, D.; Bulian, P.; Franco, V.; Del Poeta, G.; Deaglio, S.; Gaidano, G.; Tedesco, F.; Malavasi, F.; Gattei, V. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Cancer Res., 2009, 69(9), 4001-4009.
150. Wu, Q. L.; Buhtoiarov, I. N.; Sondel, P. M.; Rakhmilevich, A. L.; Ranheim, E. A. Tumoricidal effects of activated macrophages in a mouse model of chronic lymphocytic leukemia. J. Immunol., 2009, 182(11), 6771-6778.
151. Yu, J. L.; Rak, J. W. Host microenvironment in breast cancer development: inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Res., 2003, 5(2), 83-88.
152. Lin, E. Y.; Li, J. F.; Gnatovskiy, L.; Deng, Y.; Zhu, L.; Grzesik, D. A.; Qian, H.; Xue, X. N.; Pollard, J. W. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res., 2006, 66(23), 11238-11246.
153. Ribatti, D. Is angiogenesis essential for the progression of hematological malignancies or is it an epiphenomenon? Leukemia, 2009, 23(3), 433-434.
154. Ribatti, D.; Vacca, A. The role of monocytes-macrophages in vasculogenesis in multiple myeloma. Leukemia, 2009, 23(9), 1535-1536.
155. Monick, M. M.; Mallampalli, R. K.; Bradford, M.; McCoy, D.; Gross, T. J.; Flaherty, D. M.; Powers, L. S.; Cameron, K.; Kelly, S.; Merrill, A. H., Jr.; Hunninghake, G. W. Cooperative prosurvival activity by ERK and Akt in human alveolar macrophages is dependent on high levels of acid ceramidase activity. J. Immunol., 2004, 173(1), 123-135.
156. Roodman, G. D. Pathogenesis of myeloma bone disease. Leukemia, 2009, 23(3), 435-441.
157. Hideshima, T.; Mitsiades, C.; Tonon, G.; Richardson, P. G.; Anderson, K. C. Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat. Rev. Cancer, 2007, 7(8), 585-598.
158. Ryu, J.; Kim, H. J.; Chang, E. J.; Huang, H.; Banno, Y.; Kim, H. H. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. Embo J., 2006, 25(24), 5840-5851.
159. Ishii, M.; Egen, J. G.; Klauschen, F.; Meier-Schellersheim, M.; Saeki, Y.; Vacher, J.; Proia, R. L.; Germain, R. N. Sphingosine-1- phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature, 2009, 458(7237), 524-528.
160. Paugh, S. W.; Paugh, B. S.; Rahmani, M.; Kapitonov, D.; Almenara, J. A.; Kordula, T.; Milstien, S.; Adams, J. K.; Zipkin, R. E.; Grant, S.; Spiegel, S. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. Blood, 2008, 112(4), 1382-1391.